Sjölund, Jessica https://orcid.org/0000-0002-3946-0480
Kull, Inger
Bergström, Anna
Järås, Jacob
Ludvigsson, Jonas F.
Törnblom, Hans
Simrén, Magnus
Olén, Ola
Funding for this research was provided by:
Vetenskapsrådet (2018-02566, 2017-02529, 2018-02524)
AFA Försäkring (190087)
Bengt Ihres Foundation (N/A)
Sahlgrenska Akademin (N/A)
Stockholms Läns Landsting (N/A)
Hjärt-Lungfonden (20180579)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2010-00451, 2017-00526)
Astma- och Allergiförbundet (F2019-0009)
FP7 Health (261357)
University of Gothenburg
Article History
Received: 14 May 2021
Accepted: 21 July 2021
First Online: 16 September 2021
Declarations
:
: Ethical permission was obtained by the Regional Ethical Review Board, Karolinska Institutet, Stockholm (DNR 93-189; 98-175; 01-478; 02-420; 2007/1634-31; 2010/1474-31/3). Written informed consent was received from the parents/guardians on behalf of their children.
: Not applicable.
: MS received unrestricted research grants from Danone Nutricia Research, and Glycom, and served as a Consultant/Advisory Board member for Danone Nutricia Research, Ironwood, Menarini, Biocodex, Genetic Analysis AS, Glycom, Arena and Adnovate, and as a speaker for Tillotts, Menarini, Kyowa-Kirin, Takeda, Shire, Biocodex, Alimentary Health, AlfaSigma, and Falk Foundation. HT has served as Consultant/Advisory Board member for Allergan and as a speaker for Tillotts, Takeda, and Shire. JFL coordinates a study on behalf of the Swedish IBD quality register (SWIBREG). This study has received funding from Janssen corporation.The other authors have no relevant conflicts of interests to disclose.